Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial.

Details

Language :

English

ISSN :

15560864

Volume :

16

Issue :

12

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

153679516

Full Text :

https://doi.org/10.1016/j.jtho.2021.07.035